{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:51:38Z","timestamp":1783785098413,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00774-020-01093-2","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T14:02:52Z","timestamp":1583589772000},"page":"589-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip fracture in Japan"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-0014","authenticated-orcid":false,"given":"Shinichi","family":"Nakatoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumito","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Iki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1503\/cmaj.081720","volume":"181","author":"G Ioannidis","year":"2009","unstructured":"Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD (2009) Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 181:265\u2013271","journal-title":"CMAJ"},{"key":"1093_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/BOT.0b013e31821e1261","volume":"26","author":"N Fukui","year":"2012","unstructured":"Fukui N, Watanabe Y, Nakano T, Sawaguchi T, Matsushita T (2012) Predictors for ambulatory ability and the change in ADL after hip fracture in patients with different levels of mobility before injury: a 1-year prospective cohort study. J Orthop Trauma 26:163\u2013171","journal-title":"J Orthop Trauma"},{"key":"1093_CR3","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00198-012-2225-1","volume":"24","author":"LJ Melton 3rd","year":"2013","unstructured":"Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Therneau TM, Amin S (2013) Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos Int 24:1689\u20131696","journal-title":"Osteoporos Int"},{"key":"1093_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ggi.12368","volume":"15","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Chen W, Sun T, Zhang Q, Liu S, Zhang Y (2015) Epidemiological characteristics and outcome in elderly patients sustaining non-simultaneous bilateral hip fracture: a systematic review and meta-analysis. Geriatr Gerontol Int 15:11\u201318","journal-title":"Geriatr Gerontol Int"},{"key":"1093_CR5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00198-015-3464-8","volume":"27","author":"H Orimo","year":"2016","unstructured":"Orimo H, Yaegashi Y, Hosoi T, Fukushima Y, Onoda T, Hashimoto T, Sakata K (2016) Hip fracture incidence in Japan: estimates of new patients in 2012 and 25-year trends. Osteoporos Int 27:1777\u20131784","journal-title":"Osteoporos Int"},{"key":"1093_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.afos.2018.03.003","volume":"4","author":"CL Cheung","year":"2018","unstructured":"Cheung CL, Ang SB, Chadha M, Chow ES, Chung YS, Hew FL, Jaisamrarn U, Ng H, Takeuchi Y, Wu CH, Xia W, Yu J, Fujiwara S (2018) An updated hip fracture projection in Asia: the Asian Federation of Osteoporosis Societies study. Osteoporos Sarcopenia 4:16\u201321","journal-title":"Osteoporos Sarcopenia"},{"key":"1093_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00198-011-1627-9","volume":"23","author":"CH Bow","year":"2012","unstructured":"Bow CH, Cheung E, Cheung CL, Xiao SM, Loong C, Soong C, Tan KC, Luckey MM, Cauley JA, Fujiwara S, Kung AW (2012) Ethnic difference of clinical vertebral fracture risk. Osteoporos Int 23:879\u2013885","journal-title":"Osteoporos Int"},{"key":"1093_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00774-013-0447-8","volume":"31","author":"S Soen","year":"2013","unstructured":"Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, Ohta H, Yoneda T, Tomomitsu T (2013) Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab 31:247\u2013257","journal-title":"J Bone Miner Metab"},{"key":"1093_CR9","unstructured":"Japan Osteoporosis Society (2015) Guidelines on the prevention and treatment of osteoporosis 2015. The committee for development of the guidelines on the prevention and treatment of osteoporosis. (In Japanese). https:\/\/www.josteo.com\/ja\/guideline\/doc\/15_1.pdf. Accessed 8 Oct 2019."},{"key":"1093_CR10","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00198-017-4175-0","volume":"28","author":"T Saito","year":"2017","unstructured":"Saito T, Sterbenz JM, Malay S, Zhong L, MacEachern MP, Chung KC (2017) Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis. Osteoporos Int 28:3289\u20133300","journal-title":"Osteoporos Int"},{"key":"1093_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical, and Economic Aspects of Osteoporosis (ESCEO), and the Committees of Scientific Advisors, and National Societies of the International Osteoporosis Foundation (IOF) (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3\u201344","journal-title":"Osteoporos Int"},{"key":"1093_CR12","unstructured":"International Osteoporosis Foundation home page (2019) Best practice framework for fracture liaison services. https:\/\/worldosteoporosisday.org\/CTF_website\/BPF_framework\/2017-bpf-framework-EN-WEB.pdf. Accessed 9 Oct 2019."},{"key":"1093_CR13","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s00198-014-2827-x","volume":"25","author":"A Wilk","year":"2014","unstructured":"Wilk A, Sajjan S, Modi A, Fan CP, Mavros P (2014) Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA. Osteoporos Int 25:2777\u20132786","journal-title":"Osteoporos Int"},{"key":"1093_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2015.01.014","volume":"128","author":"SC Kim","year":"2015","unstructured":"Kim SC, Kim MS, Sanf\u00e9lix-Gimeno G, Song HJ, Liu J, Hurtado I, Peir\u00f3 S, Lee J, Choi NK, Park BJ, Avorn J (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128:519\u2013526","journal-title":"Am J Med"},{"key":"1093_CR15","doi-asserted-by":"publisher","first-page":"e180826","DOI":"10.1001\/jamanetworkopen.2018.0826","volume":"1","author":"RJ Desai","year":"2018","unstructured":"Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM (2018) association of osteoporosis medication use after hip fracture with prevention of subsequent nonvertebral fractures: an instrumental variable analysis. JAMA Netw Open 1:e180826","journal-title":"JAMA Netw Open"},{"key":"1093_CR16","first-page":"579","volume":"24","author":"MY Cheung","year":"2018","unstructured":"Cheung MY, Ho AW, Wong SH (2018) Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012. Hong Kong Med J 24:579\u2013583","journal-title":"Hong Kong Med J"},{"key":"1093_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00223-011-9545-6","volume":"90","author":"H Hagino","year":"2012","unstructured":"Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14\u201321","journal-title":"Calcif Tissue Int"},{"key":"1093_CR18","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00198-015-3124-z","volume":"26","author":"Y Tsukutani","year":"2015","unstructured":"Tsukutani Y, Hagino H, Ito Y, Nagashima H (2015) Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis. Osteoporos Int 26:2249\u20132255","journal-title":"Osteoporos Int"},{"key":"1093_CR19","unstructured":"Ministry of Health, Labour, and Welfare (2019) The popularization and state of electronic receipt claims https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-12400000-Hokenkyoku\/0000099002.pdf. (In Japanese) Accessed 9 Oct 2019."},{"key":"1093_CR20","unstructured":"Cabinet office (2019) The state of aging https:\/\/www8.cao.go.jp\/kourei\/whitepaper\/w-2017\/html\/gaiyou\/s1_1.html. (In Japanese) Accessed 9 Oct 2019."},{"key":"1093_CR21","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/jbmr.3079","volume":"32","author":"CW Gillespie","year":"2017","unstructured":"Gillespie CW, Morin PEJ (2017) osteoporosis-related health services utilization following first hip fracture among a cohort of privately-insured women in the United States, 2008\u20132014: an observational study. Bone Miner Res 32:1052\u20131061","journal-title":"Bone Miner Res"},{"key":"1093_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.spinee.2018.08.004","volume":"19","author":"DW Barton","year":"2019","unstructured":"Barton DW, Behrend CJ, Carmouche JJ (2019) Rates of osteoporosis screening and treatment following vertebral fracture. Spine J 19:411\u2013417","journal-title":"Spine J"},{"key":"1093_CR23","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jbmr.2202","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929\u20131937","journal-title":"J Bone Miner Res"},{"key":"1093_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.maturitas.2017.06.021","volume":"103","author":"YM Yu","year":"2017","unstructured":"Yu YM, Lee JY, Lee E (2017) Access to anti-osteoporosis medication after hip fracture in Korean elderly patients. Maturitas 103:54\u201359","journal-title":"Maturitas"},{"key":"1093_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jos.2017.09.008","volume":"23","author":"K Iba","year":"2018","unstructured":"Iba K, Dohke T, Takada J, Sasaki K, Sonoda T, Hanaka M, Miyano S, Yamashita T (2018) Improvement in the rate of inadequate pharmaceutical treatment by orthopaedic surgeons for the prevention of a second fracture over the last 10 years. J Orthop Sci 23:127\u2013131","journal-title":"J Orthop Sci"},{"key":"1093_CR26","first-page":"1233","volume":"27","author":"S Nakatoh","year":"2017","unstructured":"Nakatoh S (2017) Primary fracture prevention through the osteoporosis liaison service. Clin Calcium 27:1233\u20131240","journal-title":"Clin Calcium"},{"key":"1093_CR27","first-page":"w14579","volume":"148","author":"B Aubry-Rozier","year":"2018","unstructured":"Aubry-Rozier B, Stoll D, Gonzalez Rodriguez E, Hans D, Prudent V, Seuret A, Farron A, Lamy O (2018) Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS. Swiss Med Wkly 148:w14579","journal-title":"Swiss Med Wkly"},{"key":"1093_CR28","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s00198-014-2804-4","volume":"25","author":"JE Sale","year":"2014","unstructured":"Sale JE, Bogoch E, Hawker G, Gignac M, Beaton D, Jaglal S, Frankel L (2014) Patient perceptions of provider barriers to post-fracture secondary prevention. Osteoporos Int 25:2581\u20132589","journal-title":"Osteoporos Int"},{"key":"1093_CR29","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.2106\/JBJS.G.00864","volume":"90","author":"V Rabenda","year":"2008","unstructured":"Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Jt Surg Am 90:2142\u20132148","journal-title":"J Bone Jt Surg Am"},{"key":"1093_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00198-008-0651-x","volume":"20","author":"C Roerholt","year":"2009","unstructured":"Roerholt C, Eiken P, Abrahamsen B (2009) Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int 20:299\u2013307","journal-title":"Osteoporos Int"},{"key":"1093_CR31","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00198-016-3542-6","volume":"27","author":"JPW Bynum","year":"2016","unstructured":"Bynum JPW, Bell JE, Cantu RV, Wang Q, McDonough CM, Carmichael D, Tosteson TD, Tosteson ANA (2016) Second fractures among older adults in the year following hip, shoulder, or wrist fracture. Osteoporos Int 27:2207\u20132215","journal-title":"Osteoporos Int"},{"key":"1093_CR32","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1001\/archinte.167.18.1971","volume":"167","author":"SD Berry","year":"2007","unstructured":"Berry SD, Samelson EJ, Hannan MT, McLean RR, Lu M, Cupples LA, Shaffer ML, Beiser AL, Kelly-Hayes M, Kiel DP (2007) Second hip fracture in older men and women: the Framingham Study. Arch Intern Med 167:1971\u20131976","journal-title":"Arch Intern Med"},{"key":"1093_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1359\/jbmr.090207","volume":"24","author":"J Ryg","year":"2009","unstructured":"Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977\u20132001. J Bone Miner Res 24:1299\u20131307","journal-title":"J Bone Miner Res"},{"key":"1093_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.aott.2016.06.008","volume":"50","author":"SH Lee","year":"2016","unstructured":"Lee SH, Chen IJ, Li YH, Fan Chiang CY, Chang CH, Hsieh PH (2016) Incidence of second hip fractures and associated mortality in Taiwan: a nationwide population-based study of 95,484 patients during 2006\u20132010. Acta Orthop Traumatol Turc 50:437\u2013442","journal-title":"Acta Orthop Traumatol Turc"},{"key":"1093_CR35","unstructured":"Geospatial Information Authority of Japan (2019) Area according to administrative divisions https:\/\/www.gsi.go.jp\/KOKUJYOHO\/MENCHO\/201810\/area_todoufuken.pdf. (in Japanese) Accessed 9 Oct 2019."},{"key":"1093_CR36","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00198-019-04844-8","volume":"30","author":"J Tamaki","year":"2019","unstructured":"Tamaki J, Fujimori K, Ikehara S, Kamiya K, Nakatoh S, Okimoto N, Ogawa S, Ishii S, Iki M, Working Group of Japan Osteoporosis Foundation (2019) Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012\u20132015. Osteoporos Int 30:975\u2013983","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-020-01093-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:44:32Z","timestamp":1615077872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-020-01093-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1007\/s00774-020-01093-2","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,7]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"S. Nakatoh has received lecture fees from Asahi-Kasei Pharmaceutical Co., Ltd., Pfizer Japan Inc., and Eli Lilly Japan K.K. N. Okimoto has received consulting fees from Asahi-Kasei Pharmaceutical Co., Ltd and Teijin Pharma Ltd. N. Okimoto has received payments for lectures, including speakers\u2019 bureau fees, from Asahi-Kasei Pharmaceutical Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Daiichi-Sankyo Co. Ltd., Eisai Co., Ltd., Mitsubishi-Tanabe Pharma Corp., Ono Pharmaceutical Co., Pfizer Japan Inc., Shionogi and Co., Ltd., Kaken Pharmaceutical Co. Ltd., Hisamitsu Pharmaceutical Co, Inc., and Teijin Pharma Ltd. The other authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the principles of the Declaration of Helsinki and approved by the institutional review board of Asahi General Hospital (IRB no. 19-01) and the ethics committee of Tohoku University as \u201cExamination of drug treatment compliance in osteoporosis using electronic claim database\u201d (2018-1-868). This study was a part of the \u201cmedical\/nursing care information database development project,\u201d in which the National Health Insurance Federation was instructed by the Hokkaido Government to construct the database at Tohoku University. The claim data, which were collected by KF, were provided by the governor with the approval by all municipal governments after anonymization in the National Health Insurance Federation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The data in this study were completely anonymous; thus, informed consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}